Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

DiabetologNytt Nr 1-2-2025
Senaste Nr DiabetologNytt i PDF
Arkiv alla nyheter

EASD. Revaskularisering säkert viid diabetes. NDR

Vid öppen revaskularisering används antingen ett av patientens egna kärl för att koppla förbi en förträngning eller så sätts en kärlprotes in för samma ändamål. 

 

Data samlades in från Svenska kärlregistret och Nationella diabetesregistret mellan åren 2010 och 2014.  

Utav 1 537 patienter som registrerats i Svenska kärlregistret hade 569 personer även diabetes. Uppföljningen skedde ungefär 4,5 år i median efter den öppna kärlkirurgin. 

Vid den tiden sågs ingen skillnad mellan patienter med och utan diabetes för bland annat dödlighet, kardiovaskulär död eller antalet större amputationer. Det sistnämnda handlar om amputationer av benet eller underbenet.

 

Abstract
https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcOnIi56UNy-o0j-0fL0RNjG362yJUvJiBieXgTvk_1sRp_4PNUsRese0YCDJrXsF7Q2

Diabetes is not associated with major amputation after open vascular surgery for chronic limb- threatening ischaemia: a nationwide propensity score analysis

E. Lilja1, A. Gottsäter1, M. Miftaraj2, J. Ekelund2, B. Eliasson3, A.-M. Svensson2, M. Zarrouk1, S. Acosta1;

1Department of Clinical Sciences, Lund University, Malmö, 2National Diabetes Register, Centre of Registers, Gothenburg, 3Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

Background and aims The risk of major amputation is higher after urgently planned endovascular therapy for chronic limb-threatening ischemia (CLTI) in patients with diabetes mellitus (DM). The aim of this nationwide cohort study was to compare outcomes between patients with and without DM following urgently planned open revascularization for CLTI from 2010 to 2014.

Materials and methods 
Out of 1537 individuals registered in the Swedish Vascular Registry, 569 were registered in the National Diabetes Register. A propensity score adjusted Cox regression analysis was conducted to compare outcome between the groups with and without DM. Median follow-up was 4.3 years and 4.5 years for patients with and without DM, respectively.

Results
Patients with DM more often had foot ulcers (p=0.034) and had undergone more previous amputations (p=0.001) at baseline. No differences in mortality, cardiovascular death, major adverse cardiovascular events (MACE), or major amputation were observed between groups. The incidence rate of stroke was 70% higher (95% CI 1.11-2.59; p= 0.0137) and the incidence rate of AMI 39% higher (95% CI 1.00-1.92; p=0.0472) among patients with DM in comparison to those without.

Conclusion
Open vascular surgery remains a first-line option for a substantial part of patients with CLTI, especially for limb salvage in patients with DM. The higher incidence rate of stroke and AMI among patients with DM following open vascular surgery for infrainguinal CLTI require specific consideration preoperatively with the aim of optimizing medical treatment to improve cardiovascular outcome postoperatively.

Nyhetsinfo
www red DiabetologNytt

Facebook
LinkedIn
Email
WhatsApp